Mrv1909 07092018252D 18 19 0 0 1 0 999 V2000 2.4324 -3.0882 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6119 -3.1745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1270 -2.5070 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.3020 -2.5070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0470 -1.7224 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.7376 -1.4675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3507 -2.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1353 -1.7646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3068 -0.9576 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.0915 -0.7027 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.6937 -0.4056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9091 -0.6605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2960 -0.1085 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1624 -0.6244 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1.2665 -0.6244 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1.3819 -1.7224 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.1665 -1.4675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 3 2 1 1 0 0 0 3 4 1 0 0 0 0 5 4 1 0 0 0 0 5 6 1 1 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 9 8 1 0 0 0 0 9 10 1 1 0 0 0 9 11 1 0 0 0 0 11 12 1 0 0 0 0 6 12 1 0 0 0 0 12 13 2 0 0 0 0 5 14 1 0 0 0 0 14 15 1 0 0 0 0 14 16 1 0 0 0 0 17 14 1 0 0 0 0 3 17 1 0 0 0 0 17 18 1 6 0 0 0 M END > DB15694 > drugbank > OC[C@H]1O[C@@H](N2CC[C@@H](O)NC2=O)C(F)(F)[C@@H]1O > InChI=1S/C9H14F2N2O5/c10-9(11)6(16)4(3-14)18-7(9)13-2-1-5(15)12-8(13)17/h4-7,14-16H,1-3H2,(H,12,17)/t4-,5-,6-,7-/m1/s1 > VUDZSIYXZUYWSC-DBRKOABJSA-N > C9H14F2N2O5 > 268.217 > 268.087077885 > 5 > 32 > 0.0015360506313166218 > 22.706456310779394 > 1 > 4 > 0 > 0 > (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one > -0.64 > -1.4109009796666667 > -0.17 > 0 > 0 > 2 > 0 > 11.69037280910183 > 11.000571990556669 > -2.983177788597496 > 102.26 > 51.7505 > 2 > 1 > 1.82e+02 g/l > (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one > 0 > DB15694 > approved; investigational > Cedazuridine > (4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine; Cedazuridine > Inqovi $$$$